
### [MONDO:0004670](http://purl.obolibrary.org/obo/MONDO_0004670)
**Label:** lupus erythematosus

**Subclasses:** [MONDO:0019559](http://purl.obolibrary.org/obo/MONDO_0019559) (hypertrophic or verrucous lupus erythematosus), [MONDO:0012361](http://purl.obolibrary.org/obo/MONDO_0012361) (SLEB5), [MONDO:0019557](http://purl.obolibrary.org/obo/MONDO_0019557) (Chilblain lupus), [MONDO:0018887](http://purl.obolibrary.org/obo/MONDO_0018887) (rare cutaneous lupus erythematosus), [MONDO:0019558](http://purl.obolibrary.org/obo/MONDO_0019558) (discoid lupus erythematosus), [MONDO:0013152](http://purl.obolibrary.org/obo/MONDO_0013152) (SLEB14), [MONDO:0015574](http://purl.obolibrary.org/obo/MONDO_0015574) (chronic cutaneous lupus erythematosus), [MONDO:0012584](http://purl.obolibrary.org/obo/MONDO_0012584) (systemic lupus erythematosus, susceptibility to, 9), [MONDO:0015573](http://purl.obolibrary.org/obo/MONDO_0015573) (subacute cutaneous lupus erythematosus), [MONDO:0018360](http://purl.obolibrary.org/obo/MONDO_0018360) (neonatal lupus erythematosus), [MONDO:0005403](http://purl.obolibrary.org/obo/MONDO_0005403) (neonatal systemic lupus erthematosus), [MONDO:0013739](http://purl.obolibrary.org/obo/MONDO_0013739) (Chilblain lupus 2), [MONDO:0011138](http://purl.obolibrary.org/obo/MONDO_0011138) (systemic lupus erythematosus, susceptibility to, 1), [MONDO:0012403](http://purl.obolibrary.org/obo/MONDO_0012403) (SLEB7), [MONDO:0012369](http://purl.obolibrary.org/obo/MONDO_0012369) (SLEB6), [MONDO:0012500](http://purl.obolibrary.org/obo/MONDO_0012500) (Chilblain lupus 1), [MONDO:0005282](http://purl.obolibrary.org/obo/MONDO_0005282) (cutaneous lupus erythematosus), [MONDO:0012884](http://purl.obolibrary.org/obo/MONDO_0012884) (SLEB13), [MONDO:0018827](http://purl.obolibrary.org/obo/MONDO_0018827) (familial Chilblain lupus), [MONDO:0012404](http://purl.obolibrary.org/obo/MONDO_0012404) (SLEB8), [MONDO:0016474](http://purl.obolibrary.org/obo/MONDO_0016474) (drug-induced lupus erythematosus), [MONDO:0012036](http://purl.obolibrary.org/obo/MONDO_0012036) (SLEB4), [MONDO:0011560](http://purl.obolibrary.org/obo/MONDO_0011560) (SLEB3), [MONDO:0019560](http://purl.obolibrary.org/obo/MONDO_0019560) (lupus erythematosus tumidus), [MONDO:0019561](http://purl.obolibrary.org/obo/MONDO_0019561) (lupus erythematosus panniculitis), [MONDO:0007915](http://purl.obolibrary.org/obo/MONDO_0007915) (systemic lupus erythematosus (disease)), [MONDO:0011807](http://purl.obolibrary.org/obo/MONDO_0011807) (SLEH1), [MONDO:0010433](http://purl.obolibrary.org/obo/MONDO_0010433) (SLEB15), [MONDO:0011520](http://purl.obolibrary.org/obo/MONDO_0011520) (systemic lupus erythematosus, susceptibility to, 2), [MONDO:0012836](http://purl.obolibrary.org/obo/MONDO_0012836) (SLEB12), [MONDO:0013743](http://purl.obolibrary.org/obo/MONDO_0013743) (autosomal systemic lupus erythematosus), [MONDO:0011944](http://purl.obolibrary.org/obo/MONDO_0011944) (SLEN3), [MONDO:0012835](http://purl.obolibrary.org/obo/MONDO_0012835) (systemic lupus erythematosus, susceptibility to, 11), [MONDO:0011943](http://purl.obolibrary.org/obo/MONDO_0011943) (SLEN2), [MONDO:0012834](http://purl.obolibrary.org/obo/MONDO_0012834) (systemic lupus erythematosus, susceptibility to, 10), [MONDO:0011942](http://purl.obolibrary.org/obo/MONDO_0011942) (SLEN1), 

**Mapped go classes:** [GO:2000483](http://purl.obolibrary.org/obo/GO_2000483) (negative regulation of interleukin-8 secretion), [GO:0032693](http://purl.obolibrary.org/obo/GO_0032693) (negative regulation of interleukin-10 production), [GO:1901222](http://purl.obolibrary.org/obo/GO_1901222) (regulation of NIK/NF-kappaB signaling), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0004540](http://purl.obolibrary.org/obo/GO_0004540) (ribonuclease activity), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0001820](http://purl.obolibrary.org/obo/GO_0001820) (serotonin secretion), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0004536](http://purl.obolibrary.org/obo/GO_0004536) (deoxyribonuclease activity), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway), [GO:0046061](http://purl.obolibrary.org/obo/GO_0046061) (dATP catabolic process), [GO:0034987](http://purl.obolibrary.org/obo/GO_0034987) (immunoglobulin receptor binding), [GO:0032567](http://purl.obolibrary.org/obo/GO_0032567) (dGTP binding), [GO:0050798](http://purl.obolibrary.org/obo/GO_0050798) (activated T cell proliferation), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0002253](http://purl.obolibrary.org/obo/GO_0002253) (activation of immune response), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0002924](http://purl.obolibrary.org/obo/GO_0002924) (negative regulation of humoral immune response mediated by circulating immunoglobulin), [GO:2000363](http://purl.obolibrary.org/obo/GO_2000363) (positive regulation of prostaglandin-E synthase activity), [GO:0032558](http://purl.obolibrary.org/obo/GO_0032558) (adenyl deoxyribonucleotide binding), [GO:0051898](http://purl.obolibrary.org/obo/GO_0051898) (negative regulation of protein kinase B signaling), [GO:0090314](http://purl.obolibrary.org/obo/GO_0090314) (positive regulation of protein targeting to membrane), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0005057](http://purl.obolibrary.org/obo/GO_0005057) (signal transducer activity, downstream of receptor), [GO:0038096](http://purl.obolibrary.org/obo/GO_0038096) (Fc-gamma receptor signaling pathway involved in phagocytosis), [GO:0004520](http://purl.obolibrary.org/obo/GO_0004520) (endodeoxyribonuclease activity), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0004875](http://purl.obolibrary.org/obo/GO_0004875) (complement receptor activity), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0001805](http://purl.obolibrary.org/obo/GO_0001805) (positive regulation of type III hypersensitivity), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:0060376](http://purl.obolibrary.org/obo/GO_0060376) (positive regulation of mast cell differentiation), [GO:0034165](http://purl.obolibrary.org/obo/GO_0034165) (positive regulation of toll-like receptor 9 signaling pathway), [GO:1900165](http://purl.obolibrary.org/obo/GO_1900165) (negative regulation of interleukin-6 secretion), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:1904646](http://purl.obolibrary.org/obo/GO_1904646) (cellular response to amyloid-beta), [GO:0002230](http://purl.obolibrary.org/obo/GO_0002230) (positive regulation of defense response to virus by host), [GO:0006952](http://purl.obolibrary.org/obo/GO_0006952) (defense response), [GO:0004530](http://purl.obolibrary.org/obo/GO_0004530) (deoxyribonuclease I activity), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0004527](http://purl.obolibrary.org/obo/GO_0004527) (exonuclease activity), [GO:0001811](http://purl.obolibrary.org/obo/GO_0001811) (negative regulation of type I hypersensitivity), [GO:0001812](http://purl.obolibrary.org/obo/GO_0001812) (positive regulation of type I hypersensitivity), [GO:0016064](http://purl.obolibrary.org/obo/GO_0016064) (immunoglobulin mediated immune response), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0034157](http://purl.obolibrary.org/obo/GO_0034157) (positive regulation of toll-like receptor 7 signaling pathway), [GO:0098609](http://purl.obolibrary.org/obo/GO_0098609) (cell-cell adhesion), [GO:0032494](http://purl.obolibrary.org/obo/GO_0032494) (response to peptidoglycan), [GO:1903169](http://purl.obolibrary.org/obo/GO_1903169) (regulation of calcium ion transmembrane transport), [GO:0032495](http://purl.obolibrary.org/obo/GO_0032495) (response to muramyl dipeptide), [GO:0045963](http://purl.obolibrary.org/obo/GO_0045963) (negative regulation of dopamine metabolic process), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0044877](http://purl.obolibrary.org/obo/GO_0044877) (macromolecular complex binding), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0071219](http://purl.obolibrary.org/obo/GO_0071219) (cellular response to molecule of bacterial origin), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0030183](http://purl.obolibrary.org/obo/GO_0030183) (B cell differentiation), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:1902523](http://purl.obolibrary.org/obo/GO_1902523) (positive regulation of protein K63-linked ubiquitination), [GO:0042100](http://purl.obolibrary.org/obo/GO_0042100) (B cell proliferation), [GO:0006898](http://purl.obolibrary.org/obo/GO_0006898) (receptor-mediated endocytosis), [GO:0008832](http://purl.obolibrary.org/obo/GO_0008832) (dGTPase activity), [GO:0043315](http://purl.obolibrary.org/obo/GO_0043315) (positive regulation of neutrophil degranulation), [GO:0042590](http://purl.obolibrary.org/obo/GO_0042590) (antigen processing and presentation of exogenous peptide antigen via MHC class I), [GO:0050766](http://purl.obolibrary.org/obo/GO_0050766) (positive regulation of phagocytosis), [GO:0050765](http://purl.obolibrary.org/obo/GO_0050765) (negative regulation of phagocytosis), [GO:1903980](http://purl.obolibrary.org/obo/GO_1903980) (positive regulation of microglial cell activation), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0042113](http://purl.obolibrary.org/obo/GO_0042113) (B cell activation), [GO:0007159](http://purl.obolibrary.org/obo/GO_0007159) (leukocyte cell-cell adhesion), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0001846](http://purl.obolibrary.org/obo/GO_0001846) (opsonin binding), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0001848](http://purl.obolibrary.org/obo/GO_0001848) (complement binding), [GO:0016793](http://purl.obolibrary.org/obo/GO_0016793) (triphosphoric monoester hydrolase activity), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0050777](http://purl.obolibrary.org/obo/GO_0050777) (negative regulation of immune response), [GO:0050776](http://purl.obolibrary.org/obo/GO_0050776) (regulation of immune response), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:1903753](http://purl.obolibrary.org/obo/GO_1903753) (negative regulation of p38MAPK cascade), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:1901216](http://purl.obolibrary.org/obo/GO_1901216) (positive regulation of neuron death), [GO:0001851](http://purl.obolibrary.org/obo/GO_0001851) (complement component C3b binding), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0042130](http://purl.obolibrary.org/obo/GO_0042130) (negative regulation of T cell proliferation), [GO:0045088](http://purl.obolibrary.org/obo/GO_0045088) (regulation of innate immune response), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0071225](http://purl.obolibrary.org/obo/GO_0071225) (cellular response to muramyl dipeptide), [GO:0012501](http://purl.obolibrary.org/obo/GO_0012501) (programmed cell death), [GO:0032456](http://purl.obolibrary.org/obo/GO_0032456) (endocytic recycling), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0014005](http://purl.obolibrary.org/obo/GO_0014005) (microglia development), [GO:0043508](http://purl.obolibrary.org/obo/GO_0043508) (negative regulation of JUN kinase activity), [GO:1902950](http://purl.obolibrary.org/obo/GO_1902950) (regulation of dendritic spine maintenance), [GO:1902715](http://purl.obolibrary.org/obo/GO_1902715) (positive regulation of interferon-gamma secretion), [GO:0006203](http://purl.obolibrary.org/obo/GO_0006203) (dGTP catabolic process), [GO:0042535](http://purl.obolibrary.org/obo/GO_0042535) (positive regulation of tumor necrosis factor biosynthetic process), [GO:0097242](http://purl.obolibrary.org/obo/GO_0097242) (amyloid-beta clearance), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0001788](http://purl.obolibrary.org/obo/GO_0001788) (antibody-dependent cellular cytotoxicity), [GO:0043197](http://purl.obolibrary.org/obo/GO_0043197) (dendritic spine), [GO:0002638](http://purl.obolibrary.org/obo/GO_0002638) (negative regulation of immunoglobulin production), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0031072](http://purl.obolibrary.org/obo/GO_0031072) (heat shock protein binding), [GO:0002523](http://purl.obolibrary.org/obo/GO_0002523) (leukocyte migration involved in inflammatory response), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0001798](http://purl.obolibrary.org/obo/GO_0001798) (positive regulation of type IIa hypersensitivity), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0035549](http://purl.obolibrary.org/obo/GO_0035549) (positive regulation of interferon-beta secretion), [GO:0070433](http://purl.obolibrary.org/obo/GO_0070433) (negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0045947](http://purl.obolibrary.org/obo/GO_0045947) (negative regulation of translational initiation), [GO:0060429](http://purl.obolibrary.org/obo/GO_0060429) (epithelium development), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0044853](http://purl.obolibrary.org/obo/GO_0044853) (plasma membrane raft), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0061756](http://purl.obolibrary.org/obo/GO_0061756) (leukocyte adhesion to vascular endothelial cell), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0030889](http://purl.obolibrary.org/obo/GO_0030889) (negative regulation of B cell proliferation), [GO:0071310](http://purl.obolibrary.org/obo/GO_0071310) (cellular response to organic substance), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0050856](http://purl.obolibrary.org/obo/GO_0050856) (regulation of T cell receptor signaling pathway), [GO:0019865](http://purl.obolibrary.org/obo/GO_0019865) (immunoglobulin binding), [GO:0019864](http://purl.obolibrary.org/obo/GO_0019864) (IgG binding), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway), [GO:0016358](http://purl.obolibrary.org/obo/GO_0016358) (dendrite development), [GO:0050853](http://purl.obolibrary.org/obo/GO_0050853) (B cell receptor signaling pathway), [GO:0008296](http://purl.obolibrary.org/obo/GO_0008296) (3'-5'-exodeoxyribonuclease activity), [GO:1902741](http://purl.obolibrary.org/obo/GO_1902741) (positive regulation of interferon-alpha secretion), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0001781](http://purl.obolibrary.org/obo/GO_0001781) (neutrophil apoptotic process), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:0008853](http://purl.obolibrary.org/obo/GO_0008853) (exodeoxyribonuclease III activity), [GO:0002862](http://purl.obolibrary.org/obo/GO_0002862) (negative regulation of inflammatory response to antigenic stimulus), [GO:0001774](http://purl.obolibrary.org/obo/GO_0001774) (microglial cell activation), [GO:0006308](http://purl.obolibrary.org/obo/GO_0006308) (DNA catabolic process), [GO:0050860](http://purl.obolibrary.org/obo/GO_0050860) (negative regulation of T cell receptor signaling pathway), [GO:0002865](http://purl.obolibrary.org/obo/GO_0002865) (negative regulation of acute inflammatory response to antigenic stimulus), [GO:0071663](http://purl.obolibrary.org/obo/GO_0071663) (positive regulation of granzyme B production), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0032817](http://purl.obolibrary.org/obo/GO_0032817) (regulation of natural killer cell proliferation), [GO:0050869](http://purl.obolibrary.org/obo/GO_0050869) (negative regulation of B cell activation), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0050868](http://purl.obolibrary.org/obo/GO_0050868) (negative regulation of T cell activation), [GO:0035644](http://purl.obolibrary.org/obo/GO_0035644) (phosphoanandamide dephosphorylation), [GO:0032930](http://purl.obolibrary.org/obo/GO_0032930) (positive regulation of superoxide anion generation), [GO:0008305](http://purl.obolibrary.org/obo/GO_0008305) (integrin complex), [GO:0002685](http://purl.obolibrary.org/obo/GO_0002685) (regulation of leukocyte migration), [GO:0032407](http://purl.obolibrary.org/obo/GO_0032407) (MutSalpha complex binding), [GO:0002434](http://purl.obolibrary.org/obo/GO_0002434) (immune complex clearance), [GO:0032405](http://purl.obolibrary.org/obo/GO_0032405) (MutLalpha complex binding), [GO:0006910](http://purl.obolibrary.org/obo/GO_0006910) (phagocytosis, recognition), [GO:0006911](http://purl.obolibrary.org/obo/GO_0006911) (phagocytosis, engulfment), [GO:0048169](http://purl.obolibrary.org/obo/GO_0048169) (regulation of long-term neuronal synaptic plasticity), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0034141](http://purl.obolibrary.org/obo/GO_0034141) (positive regulation of toll-like receptor 3 signaling pathway), [GO:0034145](http://purl.obolibrary.org/obo/GO_0034145) (positive regulation of toll-like receptor 4 signaling pathway), [GO:0045576](http://purl.obolibrary.org/obo/GO_0045576) (mast cell activation), [GO:0045334](http://purl.obolibrary.org/obo/GO_0045334) (clathrin-coated endocytic vesicle), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0006259](http://purl.obolibrary.org/obo/GO_0006259) (DNA metabolic process), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0030217](http://purl.obolibrary.org/obo/GO_0030217) (T cell differentiation), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010507](http://purl.obolibrary.org/obo/GO_0010507) (negative regulation of autophagy), [GO:0031663](http://purl.obolibrary.org/obo/GO_0031663) (lipopolysaccharide-mediated signaling pathway), [GO:2000566](http://purl.obolibrary.org/obo/GO_2000566) (positive regulation of CD8-positive, alpha-beta T cell proliferation), [GO:0010623](http://purl.obolibrary.org/obo/GO_0010623) (programmed cell death involved in cell development), [GO:0042993](http://purl.obolibrary.org/obo/GO_0042993) (positive regulation of transcription factor import into nucleus), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0045590](http://purl.obolibrary.org/obo/GO_0045590) (negative regulation of regulatory T cell differentiation), [GO:0098636](http://purl.obolibrary.org/obo/GO_0098636) (protein complex involved in cell adhesion), [GO:0017124](http://purl.obolibrary.org/obo/GO_0017124) (SH3 domain binding), [GO:0035458](http://purl.obolibrary.org/obo/GO_0035458) (cellular response to interferon-beta), [GO:0033030](http://purl.obolibrary.org/obo/GO_0033030) (negative regulation of neutrophil apoptotic process), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:1905898](http://purl.obolibrary.org/obo/GO_1905898) (positive regulation of response to endoplasmic reticulum stress), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0008408](http://purl.obolibrary.org/obo/GO_0008408) (3'-5' exonuclease activity), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0045123](http://purl.obolibrary.org/obo/GO_0045123) (cellular extravasation), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0019770](http://purl.obolibrary.org/obo/GO_0019770) (IgG receptor activity), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0019772](http://purl.obolibrary.org/obo/GO_0019772) (low-affinity IgG receptor activity), [GO:0055037](http://purl.obolibrary.org/obo/GO_0055037) (recycling endosome), 

**Class expressions from DL-Learner:**

- Thing 55.50%
- [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway) 50.68%
- [GO:0050851](http://purl.obolibrary.org/obo/GO_0050851) (antigen receptor-mediated signaling pathway) 50.68%
- [GO:0038096](http://purl.obolibrary.org/obo/GO_0038096) (Fc-gamma receptor signaling pathway involved in phagocytosis) 50.68%
- [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II) 50.68%
- [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway) 50.68%
- [GO:0002524](http://purl.obolibrary.org/obo/GO_0002524) (hypersensitivity) 50.68%
- [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II) 50.68%
- [GO:0002495](http://purl.obolibrary.org/obo/GO_0002495) (antigen processing and presentation of peptide antigen via MHC class II) 50.68%
- [GO:0002445](http://purl.obolibrary.org/obo/GO_0002445) (type II hypersensitivity) 50.68%
- [GO:0002438](http://purl.obolibrary.org/obo/GO_0002438) (acute inflammatory response to antigenic stimulus) 50.68%
- [GO:0001794](http://purl.obolibrary.org/obo/GO_0001794) (type IIa hypersensitivity) 50.68%
- [GO:0001788](http://purl.obolibrary.org/obo/GO_0001788) (antibody-dependent cellular cytotoxicity) 50.68%
- [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response) and [GO:0019724](http://purl.obolibrary.org/obo/GO_0019724) (B cell mediated immunity) 50.68%
- [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response) and [GO:0016064](http://purl.obolibrary.org/obo/GO_0016064) (immunoglobulin mediated immune response) 50.68%


